The contrast between the incidence of cells with mutations in p53 and those with mutations in Caspase-8 (<1%) is striking, prompting questions about the overall role of Caspase-8 as a “tumor suppressor” [64,65]. This evidence concerns the gene TP53 and neoplasm.